Literature DB >> 32925627

Fecal Microbiota Transplantation for the Treatment of Refractory Recurrent Urinary Tract Infection.

Sarah E S Jeney1, Felicia Lane, Andrew Oliver, Katrine Whiteson, Sonia Dutta.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32925627      PMCID： PMC8328471          DOI： 10.1097/AOG.0000000000004052

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN： 0029-7844            Impact factor:   7.661


× No keyword cloud information.
  8 in total

1.  Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection Reduces Recurrent Urinary Tract Infection Frequency.

Authors:  Raseen Tariq; Darrell S Pardi; Pritish K Tosh; Randall C Walker; Raymund R Razonable; Sahil Khanna
Journal:  Clin Infect Dis       Date:  2017-10-30       Impact factor: 9.079

2.  American Urogynecologic Society Best-Practice Statement: Recurrent Urinary Tract Infection in Adult Women.

Authors:  Linda Brubaker; Cassandra Carberry; Rahel Nardos; Charelle Carter-Brooks; Jerry L Lowder
Journal:  Female Pelvic Med Reconstr Surg       Date:  2018 Sep/Oct       Impact factor: 2.091

3.  Gut microbial and metabolomic profiles after fecal microbiota transplantation in pediatric ulcerative colitis patients.

Authors:  David J Nusbaum; Fengzhu Sun; Jie Ren; Zifan Zhu; Natalie Ramsy; Nicholas Pervolarakis; Sachin Kunde; Whitney England; Bei Gao; Oliver Fiehn; Sonia Michail; Katrine Whiteson
Journal:  FEMS Microbiol Ecol       Date:  2018-09-01       Impact factor: 4.194

4.  Fecal microbiota transplantation in a kidney transplant recipient with recurrent urinary tract infection.

Authors:  Lena M Biehl; Rebeca Cruz Aguilar; Fedja Farowski; Werner Hahn; Angela Nowag; Hilmar Wisplinghoff; Maria J G T Vehreschild
Journal:  Infection       Date:  2018-08-14       Impact factor: 3.553

5.  Centrifuge: rapid and sensitive classification of metagenomic sequences.

Authors:  Daehwan Kim; Li Song; Florian P Breitwieser; Steven L Salzberg
Journal:  Genome Res       Date:  2016-10-17       Impact factor: 9.043

6.  Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.

Authors:  Daniel Dindo; Nicolas Demartines; Pierre-Alain Clavien
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

7.  Recovery of the gut microbiome following fecal microbiota transplantation.

Authors:  Anna M Seekatz; Johannes Aas; Charles E Gessert; Timothy A Rubin; Daniel M Saman; Johan S Bakken; Vincent B Young
Journal:  MBio       Date:  2014-06-17       Impact factor: 7.867

8.  Trimmomatic: a flexible trimmer for Illumina sequence data.

Authors:  Anthony M Bolger; Marc Lohse; Bjoern Usadel
Journal:  Bioinformatics       Date:  2014-04-01       Impact factor: 6.937
  8 in total
  3 in total

1.  Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study.

Authors:  Cristina Graziani; Lucrezia Laterza; Claudia Talocco; Marco Pizzoferrato; Nicoletta Di Simone; Silvia D'Ippolito; Caterina Ricci; Jacopo Gervasoni; Silvia Persichilli; Federica Del Chierico; Valeria Marzano; Stefano Levi Mortera; Aniello Primiano; Andrea Poscia; Francesca Romana Ponziani; Lorenza Putignani; Andrea Urbani; Valentina Petito; Federica Di Vincenzo; Letizia Masi; Loris Riccardo Lopetuso; Giovanni Cammarota; Daniela Romualdi; Antonio Lanzone; Antonio Gasbarrini; Franco Scaldaferri
Journal:  J Pers Med       Date:  2022-06-20

2.  Transmission of Antibiotic-Susceptible Escherichia coli Causing Urinary Tract Infections in a Fecal Microbiota Transplantation Recipient: Consequences for Donor Screening?

Authors:  Karuna E W Vendrik; Tim G J de Meij; Arend Bökenkamp; Rogier E Ooijevaar; Bas Groenewegen; Antoni P A Hendrickx; Elisabeth M Terveer; Ed J Kuijper; Joffrey van Prehn
Journal:  Open Forum Infect Dis       Date:  2022-06-29       Impact factor: 4.423

Review 3.  The Microbiome and Gynecologic Cancer: Current Evidence and Future Opportunities.

Authors:  Laura M Chambers; Parker Bussies; Roberto Vargas; Emily Esakov; Surabhi Tewari; Ofer Reizes; Chad Michener
Journal:  Curr Oncol Rep       Date:  2021-06-14       Impact factor: 5.075
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.